SCHEMBL9106674

SCHEMBL9106674

CCOC(=O)c1c(NC=C2C(=O)OC(C)(C)OC2=O)c[nH]c1C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 0.49
SMN1; SMN2 Q16637 2/20 0.42
HSD17B10 Q99714 3/20 0.42
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
RAB9A P51151 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 2/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10258317 0.85 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HSD17B10RAB9ACYP1A2
SCHEMBL9105704 0.84 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HSD17B10RAB9ACYP1A2
SCHEMBL7687953 0.77 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2HSD17B10CASP1CASP7
SCHEMBL8107490 0.73 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2HSD17B10RAB9ACYP1A2
SCHEMBL24315862 0.73 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HSD17B10CASP1CASP7
SCHEMBL27167381 0.73 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HSD17B10CASP1CASP7
SCHEMBL2801691 0.72 RAB9A (0.49) ALDH1A1HSD17B10CASP1CASP7RAB9A
SCHEMBL27167397 0.72 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HSD17B10CASP1CASP7
SCHEMBL16112294 0.71 RAB9A (0.70) ALDH1A1SMN1; SMN2HSD17B10RAB9ACYP1A2
SCHEMBL9206577 0.70 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2RAB9ACYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US disclosed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US disclosed
WO-2011023696-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A ALDH1A1 1112/4885SMN1; SMN2 2053/4885HSD17B10 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.